NRX Pharmaceuticals, Inc. Common Stock (NRXP) Stock Price, Quote & AI Analysis

Live NRXP stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for NRX Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for NRX Pharmaceuticals, Inc. Common Stock (NRXP), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

NRXP
NRX Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
2.180000
High
2.236100
Low
2.060000
Volume
651,452
VWAP
-
Market Cap
$72,418,109.70
52W Range
$1.58 - $3.84
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
May 13, 2026 Q1
Market
EPS Estimate: $-0.051
Revenue Estimate: $14,535,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

NRX Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

NRX Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

Company Details
Market Cap
$69.44M
Shares Outstanding
33,067,632
Weighted Shares Outstanding
33,067,630
CEO
Jonathan C. Javitt
Address
1201 ORANGE STREET, WILMINGTON, DE, 19801
Employees
29
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

NRX Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...